US Stocks
/
Spero Therapeutics, Inc. Share Price

Spero Therapeutics, Inc. Share Price

NASDAQ: SPRO | Micro Cap
$1.14
-$0.02 (-1.72%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Spero Therapeutics, Inc. Stock Performance

Open
$1.20
Prev. Close
$1.16
Circuit Range
N/A
Day Range
$1.14 - $1.20
Year Range
$1.08 - $3.07
Volume
23,736
Average Traded
$1.15

Spero Therapeutics, Inc. Share Price Today

As of 9 October 2026, Spero Therapeutics, Inc.'s share price is $1.14. The stock opened at $1.20, compared to its previous close of $1.16. During today's trading session, Spero Therapeutics, Inc.'s share price traded between $1.14 and $1.20, with an average price of $1.17. Over the past 52 weeks, the stock has recorded a high of $3.07 and a low of $1.08. In terms of performance, Spero Therapeutics, Inc.'s share price has declined by 54.67% over the last six months and is down 53.09% on a year-on-year basis.

Spero Therapeutics, Inc. Share Price Chart

$1.14$1.20
L
Show Current Price
H

Spero Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$63.86M
PE Ratio (TTM)
8.99
Dividend Yield
0.00%
EPS (TTM)
$0.13
Revenue (TTM)
$66.80B
Return On Equity (TTM)
16.70%
Profit Margin
12.83%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-29.40%

Spero Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$5.44$41.30$0.26$0.00
Net Profit-$7.38$31.52-$7.20-$9.55
Net Profit Margin-135.66%76.32%-2769.23%N/A
Income ChangeN/A527.10%-122.84%-32.64%

Spero Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$53.51$103.78$47.98$66.80
Net Profit-$46.42$22.81-$68.57$8.57
Net Profit Margin-86.75%21.98%-142.91%12.83%
Income ChangeN/A149.14%-400.61%112.50%

About Spero Therapeutics, Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Spero Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.20
$1.14
-5.39%
Sep 2026
$1.22
$1.21
-0.82%
Aug 2026
$1.18
$1.22
+2.97%
Jul 2026
$2.22
$1.18
-46.49%
Jun 2026
$2.81
$2.21
-21.81%
May 2026
$2.60
$2.82
+12.13%
Apr 2026
$2.41
$2.52
+7.48%
Mar 2026
$2.15
$2.34
+7.34%
Feb 2026
$2.16
$2.18
-0.23%
Jan 2026
$2.33
$2.19
-6.22%
Dec 2025
$2.31
$2.33
-2.92%
Nov 2025
$2.45
$2.40
-1.23%

SPRO Share Price FAQs

What is Spero Therapeutics, Inc. share price today?

chevron-up
Spero Therapeutics, Inc. share price today is $1.14 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Spero Therapeutics, Inc. stock?

chevron-up
The 52 week high of Spero Therapeutics, Inc. stock is $3.07, while the 52 week low is $1.08 as of 9 Oct '26.

What is SPRO's market capitalisation today?

chevron-up
SPRO market capitalisation is $63.86M as of October 9, 2026, at 4:45 pm IST.

What is SPRO's net income for the last quarter?

chevron-up
SPRO's net income for the last quarter is -9.55B USD.

What is the 5 year returns of SPRO?

chevron-up
The 5 year returns of SPRO is -93.51% as on 9 Oct '26.

What is the high & low stock price of SPRO today?

chevron-up
SPRO stock price hit a high of $1.20 and low of $1.14 as of 9 Oct '26.

Can I buy SPRO shares in India?

chevron-up
Yes. You can buy SPRO in India by opening an international trading account.